Legend Biotech names ex-Novartis exec as CEO
Cell therapy developer Legend Biotech has named Ingrid Zhang as its new chief executive, ending its search for new leadership.
Newsletters and Deep Dive digital magazine
Cell therapy developer Legend Biotech has named Ingrid Zhang as its new chief executive, ending its search for new leadership.
Chinese tech giant ByteDance, best known as the parent of TikTok, has completed a $290m financing for its AI drug discovery spinout Anew Labs.
Researchers have used AI algorithms to sift through thousands of drug molecules and identify some with activity against problem pathogen S pneumoniae.
The FDA has published the design of its expedited Investigational New Drug pilot, part of a plan to restore US competitiveness in clinical research.
Electra Therapeutics has moved ahead with plans for an IPO, seeking to raise funds for its drug for the rare and life-threatening disease sHLH.
Editor's Picks
Newsletters and Deep Dive
digital magazine